144 related articles for article (PubMed ID: 35349600)
1. Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass.
Palmieri M; Joseph TE; O'Brien CA; Gomez-Acevedo H; Manolagas SC; Ambrogini E
PLoS One; 2022; 17(3):e0265893. PubMed ID: 35349600
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass.
Palmieri M; Joseph TE; O'Brien CA; Gomez-Acevedo H; Kim HN; Manolagas SC; Ambrogini E
Bone; 2023 May; 170():116702. PubMed ID: 36773885
[TBL] [Abstract][Full Text] [Related]
3. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
[TBL] [Abstract][Full Text] [Related]
4. The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro.
Tourkova IL; Dobrowolski SF; Secunda C; Zaidi M; Papadimitriou-Olivgeri I; Papachristou DJ; Blair HC
Lab Invest; 2019 Dec; 99(12):1850-1860. PubMed ID: 31467425
[TBL] [Abstract][Full Text] [Related]
5. Gender- and region-specific alterations in bone metabolism in Scarb1-null female mice.
Martineau C; Martin-Falstrault L; Brissette L; Moreau R
J Endocrinol; 2014 Aug; 222(2):277-88. PubMed ID: 24928939
[TBL] [Abstract][Full Text] [Related]
6. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.
Martineau C; Martin-Falstrault L; Brissette L; Moreau R
Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E48-57. PubMed ID: 24253048
[TBL] [Abstract][Full Text] [Related]
7. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
[TBL] [Abstract][Full Text] [Related]
8. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
9. Retinoic Acid Receptor γ Activity in Mesenchymal Stem Cells Regulates Endochondral Bone, Angiogenesis, and B Lymphopoiesis.
Green AC; Rudolph-Stringer V; Straszkowski L; Tjin G; Crimeen-Irwin B; Walia M; Martin TJ; Sims NA; Purton LE
J Bone Miner Res; 2018 Dec; 33(12):2202-2213. PubMed ID: 30040873
[TBL] [Abstract][Full Text] [Related]
10. Scavenger receptor-B1 and luteal function in mice.
Jiménez LM; Binelli M; Bertolin K; Pelletier RM; Murphy BD
J Lipid Res; 2010 Aug; 51(8):2362-71. PubMed ID: 20404351
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice.
Blair HC; Kalyvioti E; Papachristou NI; Tourkova IL; Syggelos SA; Deligianni D; Orkoula MG; Kontoyannis CG; Karavia EA; Kypreos KE; Papachristou DJ
Lab Invest; 2016 Jul; 96(7):763-72. PubMed ID: 27088511
[TBL] [Abstract][Full Text] [Related]
12. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
14. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
15. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.
Zhu W; Liang G; Huang Z; Doty SB; Boskey AL
J Biol Chem; 2011 Jul; 286(30):26794-805. PubMed ID: 21636574
[TBL] [Abstract][Full Text] [Related]
16. Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.
Zhong ZA; Kot A; Lay YE; Zhang H; Jia J; Lane NE; Yao W
J Bone Miner Res; 2017 Sep; 32(9):1841-1852. PubMed ID: 28569405
[TBL] [Abstract][Full Text] [Related]
17. Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.
Liu Y; Almeida M; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E762-73. PubMed ID: 26956187
[TBL] [Abstract][Full Text] [Related]
18. Conditional loss of CaMKK2 in Osterix-positive osteoprogenitors enhances osteoblast function in a sex-divergent manner.
Mattingly BT; Kambrath AV; Ding X; Thompson WR; Sankar U
Bone; 2024 Jul; 184():117113. PubMed ID: 38703937
[TBL] [Abstract][Full Text] [Related]
19. Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice.
Lademann F; Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Heuer H; Rauner M
Thyroid; 2020 Feb; 30(2):329-342. PubMed ID: 31910109
[No Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo.
Zhang X; Tamasi J; Lu X; Zhu J; Chen H; Tian X; Lee TC; Threadgill DW; Kream BE; Kang Y; Partridge NC; Qin L
J Bone Miner Res; 2011 May; 26(5):1022-34. PubMed ID: 21542005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
